RESEARCH-USE BIOSIMILAR ANTIBODY
Tildrakizumab
Monoclonal antibody · IgG1
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis.
TARGETIL23A
YMonoclonal antibody
CATALOGSC-BS-116
CATALOG NUMBERSC-BS-116
MOLECULAR WEIGHTApprox. 144.44 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis.
Tildrakizumab is a recombinant research-use antibody directed against IL23A.